TP53 and ovarian cancer: Kuramochi cells, considered to have one of the most closely matching genetic profiles to primary patient tumors of all commercially available ovarian cancer cell lines [25], contain a dominant negative D281Y mutation that likely causes aggregation of p53 [22, 26].